Brokerages Expect Medidata Solutions Inc (NASDAQ:MDSO) Will Post Earnings of $0.47 Per Share

Brokerages predict that Medidata Solutions Inc (NASDAQ:MDSO) will report earnings per share (EPS) of $0.47 for the current quarter, according to Zacks Investment Research. Seven analysts have made estimates for Medidata Solutions’ earnings, with estimates ranging from $0.44 to $0.52. Medidata Solutions reported earnings of $0.42 per share in the same quarter last year, which indicates a positive year-over-year growth rate of 11.9%. The business is scheduled to issue its next quarterly earnings report on Thursday, October 17th.

On average, analysts expect that Medidata Solutions will report full year earnings of $1.84 per share for the current year, with EPS estimates ranging from $1.77 to $1.93. For the next year, analysts forecast that the firm will report earnings of $2.14 per share, with EPS estimates ranging from $2.00 to $2.27. Zacks Investment Research’s EPS calculations are a mean average based on a survey of research analysts that that provide coverage for Medidata Solutions.

Medidata Solutions (NASDAQ:MDSO) last posted its quarterly earnings data on Monday, July 22nd. The company reported $0.48 earnings per share for the quarter, topping the consensus estimate of $0.17 by $0.31. Medidata Solutions had a net margin of 6.43% and a return on equity of 8.64%. The firm had revenue of $180.50 million for the quarter, compared to analysts’ expectations of $179.95 million. During the same period in the previous year, the company posted $0.43 EPS. The company’s quarterly revenue was up 15.8% compared to the same quarter last year.

Several equities analysts have weighed in on the stock. Zacks Investment Research cut shares of Medidata Solutions from a “hold” rating to a “sell” rating in a research report on Tuesday, April 16th. SunTrust Banks lifted their price objective on shares of Medidata Solutions from $85.00 to $92.25 and gave the stock a “hold” rating in a research report on Thursday, June 13th. William Blair cut shares of Medidata Solutions from an “outperform” rating to a “market perform” rating in a research report on Wednesday, June 12th. Wells Fargo & Co restated a “hold” rating on shares of Medidata Solutions in a report on Thursday, June 13th. Finally, Dougherty & Co cut shares of Medidata Solutions from a “buy” rating to a “neutral” rating in a report on Wednesday, May 1st. One analyst has rated the stock with a sell rating, eight have given a hold rating and three have issued a buy rating to the stock. The company presently has a consensus rating of “Hold” and an average price target of $84.27.

NASDAQ MDSO traded up $0.02 on Friday, hitting $91.41. 214,955 shares of the stock were exchanged, compared to its average volume of 1,031,504. Medidata Solutions has a 52-week low of $60.10 and a 52-week high of $98.60. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.56 and a quick ratio of 2.57. The company has a market cap of $5.70 billion, a P/E ratio of 95.22, a price-to-earnings-growth ratio of 6.03 and a beta of 1.21. The business’s 50-day moving average price is $90.91.

In other news, Director Robert Taylor sold 3,294 shares of the business’s stock in a transaction on Thursday, June 6th. The shares were sold at an average price of $90.88, for a total transaction of $299,358.72. Following the transaction, the director now directly owns 41,757 shares in the company, valued at approximately $3,794,876.16. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Insiders own 4.70% of the company’s stock.

A number of large investors have recently modified their holdings of the stock. BlackRock Inc. boosted its holdings in Medidata Solutions by 4.3% in the first quarter. BlackRock Inc. now owns 7,293,413 shares of the company’s stock worth $534,167,000 after purchasing an additional 297,812 shares in the last quarter. Clearbridge Investments LLC boosted its holdings in Medidata Solutions by 2.0% in the first quarter. Clearbridge Investments LLC now owns 2,545,149 shares of the company’s stock worth $186,407,000 after purchasing an additional 48,943 shares in the last quarter. Champlain Investment Partners LLC boosted its holdings in Medidata Solutions by 1.5% in the first quarter. Champlain Investment Partners LLC now owns 2,390,155 shares of the company’s stock worth $175,055,000 after purchasing an additional 35,405 shares in the last quarter. Janus Henderson Group PLC boosted its holdings in Medidata Solutions by 6.0% in the first quarter. Janus Henderson Group PLC now owns 1,837,555 shares of the company’s stock worth $134,583,000 after purchasing an additional 103,716 shares in the last quarter. Finally, Nikko Asset Management Americas Inc. boosted its holdings in Medidata Solutions by 16.8% in the first quarter. Nikko Asset Management Americas Inc. now owns 1,259,943 shares of the company’s stock worth $92,278,000 after purchasing an additional 181,553 shares in the last quarter.

Medidata Solutions Company Profile

Medidata Solutions, Inc provides cloud-based solutions for life sciences worldwide. It offers the Medidata Clinical Cloud, a platform, pioneering analytics, and clinical technology for the development and commercialization of new therapies. The company's platform solutions include data capture and management, and trial planning and management.

Read More: The Structure of a Futures Contract

Get a free copy of the Zacks research report on Medidata Solutions (MDSO)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Medidata Solutions (NASDAQ:MDSO)

Receive News & Ratings for Medidata Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medidata Solutions and related companies with MarketBeat.com's FREE daily email newsletter.